Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J. Kerr

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|January 18, 2003
Immune enhancement of nitroreductase-induced cytotoxicity: studies using a bicistronic adenovirus vectorNicola K Green, Iain A McNeish, Rajeev Doshi, et al.
Journal of Drug Targeting|July 11, 2003
Use of a phage display library to identify oligopeptides binding to the lumenal surface of polarized endothelium by ex vivo perfusion of human umbilical veinsFukuto Maruta, Alan L Parker, Kerry D Fisher, et al.
Ebiomedicine|September 3, 2021
Automated assessment of CD8<sup>+</sup> T-lymphocytes and stroma fractions complement conventional staging of colorectal cancerDan Jiang, Tarjei S Hveem, Mark Glaire, et al.
Oncology|March 8, 2007
Identification of an oligopeptide binding to hepatocellular carcinomaAkira Shimizu, Fukuto Maruta, Noriyuki Akita, et al.
Clinical Pharmacokinetics|October 20, 2005
Single-dose clinical pharmacokinetic studies of gefitinibHelen C Swaisland, Robert P Smith, Alison Laight, et al.
Nature Reviews. Cancer|April 4, 2008
The challenge of cancer control in AfricaRebecca J Lingwood, Peter Boyle, Alan Milburn, et al.
Cancer Science|September 21, 2006
Identification of oligopeptides binding to peritoneal tumors of gastric cancerNoriyuki Akita, Fukuto Maruta, Leonard W Seymour, et al.
Oncogene|August 13, 2002
Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A(2) and 5-lipoxygenase catalyzed pathwayPaul M Taylor, Richard J Woodfield, Matthew N Hodgkin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2010
HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapyOmar Khan, Susan Fotheringham, Victoria Wood, et al.
Scientific Reports|March 13, 2025
Activin A affects colorectal cancer progression and immunomodulation in a stage dependent mannerMark B Wiley, Jessica Bauer, Valentina Alvarez, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|January 18, 2003
Immune enhancement of nitroreductase-induced cytotoxicity: studies using a bicistronic adenovirus vectorNicola K Green, Iain A McNeish, Rajeev Doshi, et al.
Journal of Drug Targeting|July 11, 2003
Use of a phage display library to identify oligopeptides binding to the lumenal surface of polarized endothelium by ex vivo perfusion of human umbilical veinsFukuto Maruta, Alan L Parker, Kerry D Fisher, et al.
Ebiomedicine|September 3, 2021
Automated assessment of CD8<sup>+</sup> T-lymphocytes and stroma fractions complement conventional staging of colorectal cancerDan Jiang, Tarjei S Hveem, Mark Glaire, et al.
Oncology|March 8, 2007
Identification of an oligopeptide binding to hepatocellular carcinomaAkira Shimizu, Fukuto Maruta, Noriyuki Akita, et al.
Clinical Pharmacokinetics|October 20, 2005
Single-dose clinical pharmacokinetic studies of gefitinibHelen C Swaisland, Robert P Smith, Alison Laight, et al.
Nature Reviews. Cancer|April 4, 2008
The challenge of cancer control in AfricaRebecca J Lingwood, Peter Boyle, Alan Milburn, et al.
Cancer Science|September 21, 2006
Identification of oligopeptides binding to peritoneal tumors of gastric cancerNoriyuki Akita, Fukuto Maruta, Leonard W Seymour, et al.
Oncogene|August 13, 2002
Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A(2) and 5-lipoxygenase catalyzed pathwayPaul M Taylor, Richard J Woodfield, Matthew N Hodgkin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2010
HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapyOmar Khan, Susan Fotheringham, Victoria Wood, et al.
Scientific Reports|March 13, 2025
Activin A affects colorectal cancer progression and immunomodulation in a stage dependent mannerMark B Wiley, Jessica Bauer, Valentina Alvarez, et al.
Pageof 9